Skip to content

Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day

Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04547582
Acronym
SCS-90
Enrollment
4
Registered
2020-09-14
Start date
2021-05-27
Completion date
2023-07-03
Last updated
2026-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phantom Limb Pain, Traumatic Amputation of Lower Extremity

Keywords

Phantom Limb Pain, Lower-Limb Amputation, electrodes, stimulation, BKA, pain, sensation

Brief summary

The goals of this study are to provide sensory information to amputees and reduce phantom limb pain via electrical stimulation of the lumbar spinal cord and spinal nerves. The spinal nerves convey sensory information from peripheral nerves to higher order centers in the brain. These structures still remain intact after amputation and electrical stimulation of the dorsal spinal nerves in individuals with intact limbs and amputees has been demonstrated to generate paresthetic sensory percepts referred to portions of the distal limb. Further, there is recent evidence that careful modulation of stimulation parameters can convert paresthetic sensations to more naturalistic ones when stimulating peripheral nerves in amputees. However, it is currently unclear whether it is possible to achieve this same conversion when stimulating the spinal nerves, and if those naturalistic sensations can have positive effects on phantom limb pain. As a first step towards those goals, in this study, the investigators will quantify the sensations generated by electrical stimulation of the spinal nerves, study the relationship between stimulation parameters and the quality of those sensations, measure changes in control of a prosthesis with sensory stimulation, and quantify the effects of that stimulation on the perception of the phantom limb and any associated pain.

Detailed description

During the study, FDA-cleared spinal cord stimulator leads will be placed in the lumbar epidural space of lower limb amputees and steered laterally towards the dorsal spinal roots under fluoroscopic guidance. This approach is essentially identical to the FDA-cleared procedure in which these devices are placed in the lumbar epidural space for treatment of intractable low back and leg pain. In that procedure, it is common clinical practice to place 2-3 leads temporarily in the epidural space through a percutaneous approach and perform a multiday trial to determine if the patient experiences any pain reduction from spinal cord stimulation. Following the trial, the percutaneous leads are surgically removed, and the patient is referred to a neurosurgeon for permanent surgical implantation. Similarly, in this study, the device will be tunneled percutaneously through the skin and anchored in place. Using the stylet included with the spinal cord stimulator leads, the devices will be steered laterally under fluoroscopic guidance to target the dorsal spinal nerves. During lab experiments, the leads will be connected to an external stimulator. In this study, the devices will remain in the epidural space for up to 90 days and will be surgically removed. Throughout the study, the investigators will perform a series of psychophysical evaluations to characterize the sensory percepts evoked by epidural stimulation, along with functional evaluations of the effects of stimulation on the ability to control a prosthetic limb. In addition, the investigators will perform surveys to characterize changes in phantom limb sensation and pain that occur during stimulation.

Interventions

DEVICESpinal cord stimulator

Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Lee Fisher, PhD
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects must have an amputation of one lower limb, at a level between the ankle and knee joints. Minor amputation of the contralateral limb (i.e. toes or partial foot) is not exclusionary. 2. Subjects must be over 6 months post-amputation at the time of lead placement. 3. Subjects must be between the ages of 22 and 70 years old. Participants outside this age range may be at an increased medical risk and have an increased risk of fatigue during testing. 4. Subjects must have used their current prosthesis for at least 6 months and achieved at least K-1 ambulator status at the time of lead placement, as determined by the Amputee Mobility Predictor.

Exclusion criteria

1. Subjects must not have any serious disease or disorder that could affect their ability to participate in this study. 2. Female subjects of childbearing age must not be pregnant or breast-feeding. 3. Subjects must not be receiving medications that affect blood coagulation. 4. Subjects must not have an allergy to contrast medium or renal failure that could be exacerbated by the contrast agent used in MRIs. For this study, renal insufficiency will be determined through blood work and defined as BUN of 30 or less and Creatinine of 1.5 or less. 5. Subjects may not have a hemoglobin A1c level above 8.0 mg/dl at time of implant. 6. Subjects may not have any implanted medical devices that are not cleared for MRI. 7. Subjects with a T-Score higher than 63 on the 18-question Brief Symptoms Inventory (BSI-18) who have undergone discussions with and been deemed unsuitable by the Principal Investigator, a study physician, and a psychologist 8. Subjects may not have a cardiac pacemaker. 9. Subjects may not have a cardioverter defibrillator. 10. Subjects may not be currently receiving diathermy therapy. 11. Subjects may not have an implanted infusion pump. 12. Subjects may not be immunosuppressed or currently receiving immunosuppressive medications. 13. Subjects may not have a profession (e.g. radiology technologist) or medical condition (e.g. remissory cancer involved regular follow-up x-rays) that would increase radiation exposure in the 12 months prior to starting or after ending participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Location of Evoked Sensation - Plantar Surface of Missing Foot90 daysParticipants perceiving sensation on the plantar surface of missing foot
Minimum Amplitude of Pulse Required to Evoke Sensory Percepts90 daysQuantify the threshold stimulus required to evoke sensory percepts during epidural spinal nerve stimulation.
Minimum Charge Required to Evoke a Neurophysiological Response90 daysQuantify the threshold (minimum charge) stimulus required to evoke neurophysiological responses during epidural spinal nerve stimulation
Location of Evoked Sensation - Missing Toes90 daysParticipants reporting sensation on missing toes from spinal cord stimulation.
Number of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation90 daysInvestigators will track the number of participants experiencing serious device-related adverse events, such as unresolved superficial infection resulting in lead removal, deep infection, inpatient hospitalization, withdrawal from the study due to worsening pain or intolerable dysesthesia, or fracture due to falls related to the study interventions, that occur during the course of and up to 90 days following implantation.

Secondary

MeasureTime frameDescription
Qualitative Self-report of Evoked Sensations90 daysDocument the subjective perception of lumbosacral epidural spinal nerve stimulation for restoration of sensation. The investigators will ask each subject to provide subjective feedback on their perceived utility of the sensory feedback provided by the device. A total of 13 natural descriptors and 5 paresthetic descriptors were presented to participants weekly to describe the sensation provided via spinal cord stimulation. The goal of the study is to elicit more natural than paresthetic descriptors from participants. Natural: pressure, tickle, flutter, warm, sharp, prick, cool, pulsing, vibration, itch, urge to move, touch, tap Parethetic: buzz, tingle, shock, electric current, numb
Able to Use a Prosthetic Limb With Neural Signals90 daysInvestigators will test the subject's success rate during control of prosthetic limb with and without sensory feedback provided by electrical stimulation of the spinal roots. Using either a virtual prosthetic limb or an instrumented prosthesis, stimulation of the spinal roots will be modulated based on signals recorded from the limb.
Change in Phantom Limb Pain Using the McGill Pain QuestionnairePre-implant (baseline), Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and post-explant (90 days)The McGill Pain Questionnaire is a questionnaire used to evaluate the severity of pain experienced by the participant. The questionnaire is scaled, with a minimum and maximum pain score of 0 and 78, respectively. The higher the score on the questionnaire, the more intense the pain felt by the participant. A lower score than previously reported represents a decrease in experienced phantom limb pain. Before placement of the spinal cord stimulator leads, investigators will document the subject's description of their history of perceived phantom limb. Investigators will ask them to periodically update their perception of the limb throughout experimental sessions, as well as within a month after the device has been removed.

Countries

United States

Participant flow

Recruitment details

Subjects were enrolled from 2021 to 2023 from affiliated amputee clinics. Recruitment continued through 2025, but no additional subjects were enrolled.

Pre-assignment details

Enrollment is defined as completing informed consent.

Participants by arm

ArmCount
Spinal Cord Stimulation
Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation. Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders. Spinal cord stimulator: Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.
1
Total1

Baseline characteristics

CharacteristicSpinal Cord Stimulation
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
1 Participants
Region of Enrollment
United States
1 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1
other
Total, other adverse events
1 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

Location of Evoked Sensation - Missing Toes

Participants reporting sensation on missing toes from spinal cord stimulation.

Time frame: 90 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Spinal cord stimulationLocation of Evoked Sensation - Missing Toes1 Participants
Primary

Location of Evoked Sensation - Plantar Surface of Missing Foot

Participants perceiving sensation on the plantar surface of missing foot

Time frame: 90 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Spinal cord stimulationLocation of Evoked Sensation - Plantar Surface of Missing Foot1 Participants
Primary

Minimum Amplitude of Pulse Required to Evoke Sensory Percepts

Quantify the threshold stimulus required to evoke sensory percepts during epidural spinal nerve stimulation.

Time frame: 90 days

ArmMeasureValue (NUMBER)
Spinal cord stimulationMinimum Amplitude of Pulse Required to Evoke Sensory Percepts2 milliamps
Primary

Minimum Charge Required to Evoke a Neurophysiological Response

Quantify the threshold (minimum charge) stimulus required to evoke neurophysiological responses during epidural spinal nerve stimulation

Time frame: 90 days

ArmMeasureValue (NUMBER)
Spinal cord stimulationMinimum Charge Required to Evoke a Neurophysiological Response1.23 uC (microcoulombs)
Primary

Number of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation

Investigators will track the number of participants experiencing serious device-related adverse events, such as unresolved superficial infection resulting in lead removal, deep infection, inpatient hospitalization, withdrawal from the study due to worsening pain or intolerable dysesthesia, or fracture due to falls related to the study interventions, that occur during the course of and up to 90 days following implantation.

Time frame: 90 days

Population: One participant was implanted with spinal cord stimulation leads.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Spinal cord stimulationNumber of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation0 Participants
Secondary

Able to Use a Prosthetic Limb With Neural Signals

Investigators will test the subject's success rate during control of prosthetic limb with and without sensory feedback provided by electrical stimulation of the spinal roots. Using either a virtual prosthetic limb or an instrumented prosthesis, stimulation of the spinal roots will be modulated based on signals recorded from the limb.

Time frame: 90 days

Population: Individuals implanted with spinal cord stimulator leads in lumbar spine

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Spinal cord stimulationAble to Use a Prosthetic Limb With Neural Signals1 Participants
Secondary

Change in Phantom Limb Pain Using the McGill Pain Questionnaire

The McGill Pain Questionnaire is a questionnaire used to evaluate the severity of pain experienced by the participant. The questionnaire is scaled, with a minimum and maximum pain score of 0 and 78, respectively. The higher the score on the questionnaire, the more intense the pain felt by the participant. A lower score than previously reported represents a decrease in experienced phantom limb pain. Before placement of the spinal cord stimulator leads, investigators will document the subject's description of their history of perceived phantom limb. Investigators will ask them to periodically update their perception of the limb throughout experimental sessions, as well as within a month after the device has been removed.

Time frame: Pre-implant (baseline), Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and post-explant (90 days)

ArmMeasureGroupValue (NUMBER)
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 538 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 632 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnairePre-implant (baseline)48 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 1 (after implant)32 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 245 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 345 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 423 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 734 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 817 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 946 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 1041 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnaireWeek 1165 score on a scale
Spinal cord stimulationChange in Phantom Limb Pain Using the McGill Pain QuestionnairePost-explant (90 days)47 score on a scale
Secondary

Qualitative Self-report of Evoked Sensations

Document the subjective perception of lumbosacral epidural spinal nerve stimulation for restoration of sensation. The investigators will ask each subject to provide subjective feedback on their perceived utility of the sensory feedback provided by the device. A total of 13 natural descriptors and 5 paresthetic descriptors were presented to participants weekly to describe the sensation provided via spinal cord stimulation. The goal of the study is to elicit more natural than paresthetic descriptors from participants. Natural: pressure, tickle, flutter, warm, sharp, prick, cool, pulsing, vibration, itch, urge to move, touch, tap Parethetic: buzz, tingle, shock, electric current, numb

Time frame: 90 days

Population: For all reported sensations, each electrode was stimulated with a 1-second long pulse train.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Spinal cord stimulationQualitative Self-report of Evoked SensationsMore natural than paresthetic descriptors.1 Participants
Spinal cord stimulationQualitative Self-report of Evoked SensationsMore paresthetic than natural descriptors.0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026